WUH: Impact of medical and surgical weight loss on lipocalin prostaglandin D2 synthase (LPGDS) and bile acid levels.

Go Back to All Clinical Trials

WUH: Impact of medical and surgical weight loss on lipocalin prostaglandin D2 synthase (LPGDS) and bile acid levels.

Brief description of study

Obesity and type 2 diabetes are medical conditions that are associated with significant health risks. These include stroke, heart disease, and kidney disease. Medical research has been attempting to identify new ways to treat both of these diseases. What clinicians have recently noticed, is the impact of a low calorie diet and weight loss surgery appears to have a profound beneficial role on both obesity and type 2 diabetes. However, the mechanism of how this is achieved remains unclear. This study will attempt to study various proteins and hormone levels that may become altered with dietary restriction and weight loss surgery. Specifically, the research laboratory has studied and identified a protein known as “Lipocalin Prostaglandin D2 Synthase.” It appears to be associated with both obesity and type 2 diabetes. This protein and various others will be examined to better understand their biologic roles.

Clinical Study Identifier: s18-01701

Principal Investigator: Raymond Lau.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies